G
Gisela Pinero
Publications - 3
Citations - 321
Gisela Pinero is an academic researcher. The author has contributed to research in topics: Spontaneous bacterial peritonitis & Interquartile range. The author has an hindex of 2, co-authored 2 publications receiving 149 citations.
Papers
More filters
Journal ArticleDOI
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
Salvatore Piano,Virendra Singh,Paolo Caraceni,Rakhi Maiwall,Carlo Alessandria,Javier Romaní Fernández,Elza Cotrim Soares,Dong Joon Kim,Sung Eun Kim,M. Marino,Julio Vorobioff,Rita de Cassia Ribeiro Barea,Manuela Merli,Laure Elkrief,Victor Vargas,Aleksander Krag,Shivaram Prasad Singh,Laurentius A. Lesmana,C. Toledo,Sebastián Marciano,Xavier Verhelst,Florence Wong,Nicolas M. Intagliata,Liane Rabinowich,Luis Colombato,Sang Gyune Kim,Alexander L. Gerbes,François Durand,Juan Pablo Roblero,Kalyan Ram Bhamidimarri,Thomas D. Boyer,M. V. Maevskaya,Eduardo Fassio,Hyoung Su Kim,Jae Seok Hwang,Pere Ginès,Adrián Gadano,Shiv Kumar Sarin,Paolo Angeli,Michele Bartoletti,Carlos Brodersen,Tony Bruns,Robert A. de Man,Annette Dam Fialla,Carmine Gambino,Vikas Gautam,Marcos Girala,Adrià Juanola,Jeong Han Kim,Tae Hun Kim,Pramod Kumar,Barbara Lattanzi,Tae Hee Lee,Cosmas A. Rinaldi Lesmana,Richard Moreau,Preetam Nath,Gustavo Navarro,Ji Won Park,Gisela Pinero,Nikolaos Pyrsopoulos,Sophie Restellini,Gustavo Romero,Marco Sacco,Tiago Sevá-Pereira,Macarena Simón-Talero,Do Seon Song,Ki Tae Suk,Hans Van Vlierberghe,Sun Young Yim,E.L. Yoon,Giacomo Zaccherini +70 more
TL;DR: Differences in the prevalence of MDR bacterial infections in different global regions indicate the need for different empirical antibiotic strategies in different continents and countries.
Journal ArticleDOI
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure.
Florence Wong,Salvatore Piano,Virendra Singh,Michele Bartoletti,Rakhi Maiwall,Carlo Alessandria,Javier Fernández,Elza Cotrim Soares,Dong Joon Kim,Sung Eun Kim,M. Marino,Julio Vorobioff,Rita de Cassia Ribeiro Barea,Manuela Merli,Laure Elkrief,Victor Vargas,Aleksander Krag,Shivaram Prasad Singh,Laurentius A Lesmana,C. Toledo,Sebastián Marciano,Xavier Verhelst,Nicolas M. Intagliata,Liane Rabinowich,Luis Colombato,Sang Gyune Kim,Alexander L. Gerbes,François Durand,Juan Pablo Roblero,Tony Bruns,E.L. Yoon,Marcos Girala,Nikolaos Pyrsopoulos,Tae Hun Kim,Sun Young Yim,Adrià Juanola,Adrian Gadano,Paolo Angeli,Kalyan Ram Bhamidimarri,Thomas D. Boyer,Carlos Brodersen,Daniela Campion,Paolo Caraceni,Robert A. de Man,Eduardo Fassio,Annette Dam Fialla,Carmine Gambino,Vikas Gautam,Pere Ginès,Jae Seok Hwang,Hyoung Su Kim,Jeong Han Kim,Pramod Kumar,Barbara Lattanz,Tae Hee Lee,Cosmas A. Rinaldi Lesmana,M. V. Maevskaya,Preetam Nath,Gustavo Navarro,Ji Won Park,Gisela Pinero,Sophie Restellini,Gustavo Romero,Tiago Sevá Pereira,Macarena Simón-Talero,Do Seon Song,Ki Tae Suk,Hans Van Vlierberghe,Giacomo Zaccherini +68 more
TL;DR: Bacterial infections, especially with XDR organisms, present the highest risks for ACLF development amongst patients with advanced liver and renal dysfunction, and Geographic differences in these factors have resulted in variability in epidemiology, and clinical outcomes of bacterial infections and ACLF.
Journal ArticleDOI
P430 Mesalazine dose modification based on fecal calprotectin levels in ulcerative colitis patients in clinical remission
Gisela Pinero,Míriam Mañosa,Fiorella Cañete,M Calafat,L. González,Orlando Ruffinengo,È. Domènech +6 more
TL;DR: In this paper , the authors evaluated the suitability of mesalazine dose modification based on Calprotectin (FC) levels in asymptomatic ulcerative colitis patients.